We are part of the Sartorius Stedim Biotech Group, a global provider of laboratory and pharmaceutical equipment.

Based near Cambridge UK, we specialize in the design and manufacture of automated cell culture and fermentation systems for the bio-pharma, regenerative medicine and industrial biotechnology sectors, focusing on:


  • Bioprocess development
  • GMP manufacture of biologics
  • Cell therapy and stem cell research
  • Discovery research

 

 

News

New ambr® 250 Modular Bioreactor Vessel Launched for Cell and Gene Therapy Applications More >>


Sartorius Stedim Biotech launches new ambr(R) 15 cell culture microbioreactor system More >>


Sartorius Stedim Biotech Introduces Mini Microcarrier Bioreactor for Culturing Adherent Cells More >>


Sartorius Stedim Biotech launches new ambr® 250 high throughput bioreactor system for perfusion culture More >>


Engineer Wins Second Cambridge Regional College Award More >>


Ingenza invests in ambr 250 modular technology for fast fermentation development More >>


Local Firms Invited to Join Exciting STEM Initiative - Helping Children Understand the Appliance of Science More >>


Sartorius Stedim Biotech launches ambr® 15 bioreactor system with Nova BioProfile® FLEX2 integration More >>


Sartorius Stedim Biotech Partners with Nova Biomedical - Firms combine ambr® technology with the BioProfile® FLEX2 More >>


Award-Winning Engineering Apprenticeship Scheme at Royston site now open for applications More >>


New Webinar on Implementing the ambr® 250 Modular Benchtop Bioreactor - With A Case Study From Cobra Biologics More >>


New Webinar on Developing Process Workflows for Rapid Scale-Up - With a Case Study from WuXi Biologics More >>


Sartorius Stedim Biotech launches innovative ambr® 250 modular bioreactor system More >>


WuXi Biologics and Sartorius Stedim Biotech Open Joint R&D Biologics Laboratory in Shanghai More >>


New Poster on High Density Fed-Batch Microbial Screening Using Micro Bioreactors More >>


Sartorius Royston actively recruiting for a variety of roles within this growing business More >>


Science and Technology Workshops Launched for Primary & Middle Schools More >>


Sartorius Royston wins STEM Apprenticeship Employer of the Year and Overall Employer of the Year Awards More >>


Ginkgo Bioworks chooses ambr 250 Systems to enable High Throughput Process Development of Engineered Microbes More >>


New paper from WuXi AppTec on Shortening Timelines for Bioprocessing of Protein-based Therapeutics More >>


New Webinar - ambr15 microbioreactor as a sedimentation-perfusion model More >>


New SelecT Mk5 Automated Cell Culture System Launched on Booth 1223 at SLAS More >>


New ambr 15 fermentation system for enhanced microbial strain screening More >>


RAFT 3D cell culture system to be exclusively distributed by Lonza Bioscience More >>


ReNeuron to use Cellmate Automated Cell Culture for Stem Cell-based Stroke Therapy More >>


New webinar: Using ambr 250 for effective scale-up to cGMP manufacture of biotherapeutics More >>


ambr 15 and ambr 250 bioreactor systems enhanced with Design of Experiments (DoE) software More >>


 

ambr 15 cell culture Generation 2
Focus on: On-Demand Webinar - Introducing NEW ambr® 15 cell culture
Generation 2 Launch Webinar.

The newly launched Generation 2 system is the successor to the original ambr® 15 cell culture design and provides increased flexibility, enhanced performance and extended capability to support more applications.

In this webinar Alison Rees-Manley, ambr® 15 Product Manager, and Dr. Sinyee Yau-Rose, ambr® Software Applications Product Manager, gives an overview of the new ambr® 15 cell culture Generation 2 system and its supporting ambr® clone selection powered by Umetrics® software application.

Request access to this webinar to receive the recording and listen on-demand.

 

View our latest job opportunities